Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model
1Department of Ultrasonography, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.
Background:
It was indicated that inhibition of PPARγ probably represents a novel therapy for steroid-related osteonecrosis. In this study, we investigated the preventive effects of PPARγ inhibition on steroid-related osteonecrosis in a rabbit model.
Methods:
Rabbits were randomly divided into three groups (normal group, model group and BADGE group). Osteonecrosis was induced in rabbits in the model group and the BADGE group. The BADGE group also received bisphenol a diglycidyl ether(BADGE), a PPARγ antagonist, for 6 weeks.
Results:
Histopathological results indicated that rabbits treated with BADGE exhibited significantly reduced osteonecrotic changes, incidence of osteonecrosis and bone marrow adiposity. Furthermore, BADGE-treated rabbits exhibited reduced intraosseous pressure and increased femoral blood perfusion. Micro-computed tomography and bone histomorphometry indicated that the BADGE group exhibited significantly improved bone quality and mineral appositional rate compared with the model group. Furthermore, the BADGE group showed a significant increase in circulating levels of the bone formation marker osteocalcin and reduced levels of the bone resorption marker TRACP. Overall, BADGE-treated rabbits exhibited reduced marrow adiposity concomitant with improved bone formation.
Conclusions:
In conclusion, these observations demonstrated that pharmacological inhibition of PPARγ might represent an effective therapy for steroid-related osteonecrosis in the near future.
Insights
Inhibition of PPARγ using BADGE prevented steroid-induced osteonecrosis in rabbits. This treatment improved bone quality, reduced osteonecrosis, and enhanced bone formation, suggesting a potential therapy.
Area of Science:
- Biomedical research
- Orthopedics
- Pharmacology
Background:
- Steroid-induced osteonecrosis is a significant clinical challenge.
- Peroxisome proliferator-activated receptor gamma (PPARγ) inhibition shows promise as a therapeutic strategy.
Purpose of the Study:
- To investigate the preventive effects of PPARγ inhibition on steroid-related osteonecrosis.
- To evaluate bisphenol a diglycidyl ether (BADGE) as a PPARγ antagonist in a rabbit model.
Main Methods:
- Rabbits were divided into normal, model, and BADGE-treated groups.
- Osteonecrosis was induced, and the BADGE group received a PPARγ antagonist for six weeks.
- Histopathology, micro-computed tomography, and bone histomorphometry were employed.
Main Results:
- BADGE treatment significantly reduced osteonecrotic changes and bone marrow adiposity.
- Improved bone quality, increased femoral blood perfusion, and reduced intraosseous pressure were observed.
- Enhanced bone formation markers (osteocalcin) and reduced bone resorption markers (TRACP) were noted.
Conclusions:
- Pharmacological inhibition of PPARγ, using BADGE, effectively prevented steroid-related osteonecrosis in rabbits.
- These findings support PPARγ inhibition as a potential future therapy for this condition.
More Related Videos
05:56Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
08:16X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models
Published on: September 12, 2025
Related Concept Videos
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Cancer Prevention
Some...
Cholinergic Antagonists: Pharmacokinetics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...